Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosis

被引：3
作者：
Ferenci, P. [1 ]
Dusheiko, G. [2 ]
机构：
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, A-1090 Vienna, Austria
[2] UCL Inst Liver & Digest Hlth, London, England
来源：
GUT | 2014年 / 63卷 / 07期
关键词：
CHRONIC HEPATITIS-C; GENOTYPE; INFECTION; BOCEPREVIR; TELAPREVIR; COHORT;
D O I：
10.1136/gutjnl-2013-306480
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1033 / +
页数：2
相关论文
共 14 条
  • [11] Boceprevir for Untreated Chronic HCV Genotype 1 Infection
    Poordad, Fred
    McCone, Jonathan, Jr.
    Bacon, Bruce R.
    Bruno, Savino
    Manns, Michael P.
    Sulkowski, Mark S.
    Jacobson, Ira M.
    Reddy, K. Rajender
    Goodman, Zachary D.
    Boparai, Navdeep
    DiNubile, Mark J.
    Sniukiene, Vilma
    Brass, Clifford A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    Colombato, L.
    Curciarello, J.
    Silva, M.
    Tanno, H.
    Terg, R.
    Adler, M.
    Langlet, P.
    Lasser, L.
    Nevens, F.
    Anderson, F.
    Bailey, R.
    Bilodeau, M.
    Cooper, C.
    Feinman, S. V.
    Heathcote, J.
    Levstik, M.
    Ramji, A.
    Sherman, M.
    Shafran, S.
    Yoshida, E.
    Achim, A.
    Ben Ali, S.
    Bigard, M-A.
    Bonny, C.
    Bourliere, M.
    Boyer-Darrigrand, N.
    Bronowicki, J-P.
    Canva, V.
    Couzigou, P.
    De Ledinghen, V.
    Guyader, D.
    Hezode, C.
    Larrey, D.
    Latournerie, M.
    Marcellin, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1195 - 1206
  • [12] Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection
    Reiberger, Thomas
    Rutter, Karoline
    Ferlitsch, Arnulf
    Payer, Berit Anna
    Hofer, Harald
    Beinhardt, Sandra
    Kundi, Michael
    Ferenci, Peter
    Gangl, Alfred
    Trauner, Michael
    Peck-Radosavljevic, Markus
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (07) : 602 - U124
  • [13] SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
    Rutter, K.
    Ferlitsch, A.
    Maieron, A.
    Staettermayer, A. F.
    Graziadei, I.
    Dulic, M.
    Gschwantler, M.
    Stauber, R.
    Hofer, H.
    Peck-Radosavljevic, M.
    Vogel, W.
    Trauner, M.
    Ferenci, P.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S30 - S30
  • [14] Telaprevir for Retreatment of HCV Infection
    Zeuzem, Stefan
    Andreone, Pietro
    Pol, Stanislas
    Lawitz, Eric
    Diago, Moises
    Roberts, Stuart
    Focaccia, Roberto
    Younossi, Zobair
    Foster, Graham R.
    Horban, Andrzej
    Ferenci, Peter
    Nevens, Frederik
    Muellhaupt, Beat
    Pockros, Paul
    Terg, Ruben
    Shouval, Daniel
    van Hoek, Bart
    Weiland, Ola
    Van Heeswijk, Rolf
    De Meyer, Sandra
    Luo, Don
    Boogaerts, Griet
    Polo, Ramon
    Picchio, Gaston
    Beumont, Maria
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) : 2417 - 2428
12